What Researchers Did
Researchers retrospectively analyzed the efficacy of hyperbaric oxygen therapy (HBOT) in 25 patients with hemorrhagic cystitis following pelvic radiotherapy.
What They Found
All 25 patients treated with hyperbaric oxygen therapy (HBOT) for hemorrhagic cystitis responded, with total or partial cessation of bladder bleeding. None of the patients experienced recurrence after treatment at a mean follow-up of 21.2 months, and no serious complications were reported.
What This Means for Canadian Patients
Canadian patients suffering from hemorrhagic cystitis after pelvic radiotherapy may find hyperbaric oxygen therapy (HBOT) to be a highly effective and safe non-invasive treatment option. This therapy could offer significant relief from persistent bladder bleeding when other conservative treatments have failed.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This study's retrospective design, small sample size of 25 patients, and single-center nature limit the generalizability of its findings.